MM-569: Mezigdomide, Carfilzomib, and Dexamethasone vs Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Results From the Phase 3 SUCCESSOR-2 Trial
作者
Paul Gerard Guy Richardson,Fredrik Schjesvold,Chengcheng Fu,Monique A. Hartley-Brown,Cesar Gomez,Donna Ellen Reece,Gábor Mikala,Omar Alkharabsheh,Christopher Parrish,Darrell J. White,Hang Quach,Claudio Cerchione,Vânia Hungria,Amitabha Mazumder,Marc Steffen Raab,Albert Oriol,Zehua Zhou,Alberto Rocci,Brian Yu,Meletios Athanasios Dimopoulos